CD79A and nasopharyngeal carcinoma: When adjusted for age, gender and VCA-IgA antibody titers, the calculated NPC risk was significantly reduced among individuals who carried the haplotype "ATCT" (p-value = 0.0054, OR = 0.028, 95% CI (0.002–0.341)), compared to those who carried the most common haplotype "ACCT".